北京结核病胸部肿瘤研究所的研究项目包括两部分内容,一是在世界卫生组织(WHO)全球结核病耐药监测项目的资助和指导下,在河南、山东、广东、浙江、湖北和辽宁,首次采用统一的抽样、选例、药敏试验及统计分析方法,陆续开展省内结核分枝杆菌耐药监测;二是作为2000年全国流调的重要内容之一,进行全国范围的分枝杆菌耐药性调查,并对药敏试验方法学进行探讨。 The research project of the Beijing Tuberculosis and Thoracic Tumor Research Institute consists of two parts. First, under the guidance of the World Health Organization (WHO) Global Tuberculosis Drug-Resistant Monitoring Project, research projects in Henan, Shandong, Guangdong, Zhejiang, Hubei and Liaoning were adopted for the first time Unified sampling, selection, drug susceptibility testing and statistical analysis methods, one after another to carry out the province of Mycobacterium tuberculosis drug resistance monitoring; Second, as one of the important content of the national epidemic in 2000, a nationwide Mycobacterium drug resistance Sexual investigation, and drug susceptibility testing methodology.